Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Historical Holders from Q1 2014 to Q4 2025

Symbol
FMS on NYSE
Type / Class
Equity / Ordinary Shares without par value
Shares outstanding
292,938,399
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
36,077,283
Holdings value
$949,925,808
% of all portfolios
0%
Number of holders
200
Number of buys
95
Number of sells
-83
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fresenius SE & Co. KGaA 29% -11% $2,009,053,560 -$254,188,000 83,780,382 -11% Fresenius SE & Co. KGaA 06 Mar 2025
HARRIS ASSOCIATES L P 3.9% $280,987,448 11,717,575 HARRIS ASSOCIATES L P 31 Dec 2024

Institutional Holders of Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 6,000 $143,460 $23.91 1
2025 Q3 36,077,283 $949,925,808 -$14,233,618 $26.33 200
2025 Q2 36,647,647 $1,047,265,829 +$46,401,577 $28.57 205
2025 Q1 35,046,884 $872,643,885 +$27,257,611 $24.90 196
2024 Q4 34,016,903 $770,127,628 +$5,181,159 $22.64 186
2024 Q3 33,465,014 $713,200,201 +$46,953,365 $21.30 162
2024 Q2 31,332,187 $598,136,226 -$36,537,781 $19.09 164
2024 Q1 33,213,052 $640,474,869 -$1,228,316 $19.28 167
2023 Q4 478 $9,957 $20.83 1
2023 Q3 31,988,892 $688,537,140 -$25,361,788 $21.54 141
2023 Q2 34,074,004 $815,684,422 -$114,299,425 $23.93 138
2023 Q1 38,942,580 $828,066,956 -$106,789,536 $21.26 144
2022 Q4 44,121,469 $721,088,961 +$190,525,356 $16.34 146
2022 Q3 32,540,020 $456,739,652 -$40,195,155 $14.04 128
2022 Q2 32,203,443 $802,988,372 +$53,247,405 $24.94 149
2022 Q1 30,560,935 $1,029,302,002 +$97,778,965 $33.68 170
2021 Q4 27,697,530 $899,186,174 +$54,237,223 $32.46 166
2021 Q3 25,877,051 $905,142,258 +$190,667,382 $34.97 151
2021 Q2 20,356,535 $846,020,045 +$44,462,956 $41.57 168
2021 Q1 19,343,668 $713,589,654 +$311,436,101 $36.88 162
2020 Q4 10,442,270 $434,052,852 +$61,876,044 $41.56 163
2020 Q3 9,057,344 $384,719,211 +$320,751 $42.48 172
2020 Q2 9,267,537 $401,431,401 +$18,002,385 $43.28 166
2020 Q1 8,901,263 $292,156,394 -$31,791,314 $32.80 155
2019 Q4 7,713,342 $284,217,879 +$32,073,364 $36.83 149
2019 Q3 8,231,740 $276,452,985 -$7,926,616 $33.59 145
2019 Q2 8,861,430 $348,062,753 -$263,523 $39.28 155
2019 Q1 8,854,470 $358,825,462 -$93,942,410 $40.53 170
2018 Q4 11,197,932 $362,852,378 -$140,468,202 $32.39 170
2018 Q3 14,648,840 $753,213,465 -$4,109,294 $51.42 204
2018 Q2 15,092,381 $759,917,645 -$7,637,189 $50.35 212
2018 Q1 15,258,694 $779,632,982 +$23,849,700 $51.08 220
2017 Q4 14,781,728 $776,822,291 -$202,316,542 $52.55 210
2017 Q3 18,630,515 $910,902,796 +$126,485,990 $48.89 201
2017 Q2 15,358,975 $742,311,578 -$31,281,481 $48.33 182
2017 Q1 16,525,224 $696,433,852 +$30,947,823 $42.13 180
2016 Q4 15,724,987 $663,546,094 +$4,825,820 $42.21 180
2016 Q3 15,499,807 $678,803,144 +$53,778,251 $43.77 175
2016 Q2 14,261,414 $621,611,704 +$21,962,362 $43.57 166
2016 Q1 13,770,361 $606,680,798 +$161,685,799 $44.08 166
2015 Q4 10,037,690 $419,411,816 -$44,386,388 $41.84 142
2015 Q3 11,204,016 $437,397,897 +$1,741,163 $39.01 132
2015 Q2 10,941,321 $455,113,703 -$11,866,774 $41.59 137
2015 Q1 11,763,865 $487,776,999 -$13,018,673 $41.45 135
2014 Q4 12,179,862 $452,508,333 -$28,394,296 $37.14 135
2014 Q3 12,909,049 $448,225,219 -$19,180,755 $34.70 123
2014 Q2 13,492,260 $452,087,292 -$28,829,605 $33.49 129
2014 Q1 14,341,775 $499,966,845 -$53,881,876 $34.85 124